rs141012833

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_001206927.2(DNAH8):​c.4800A>T​(p.Arg1600Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000973 in 1,613,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00055 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000051 ( 0 hom. )

Consequence

DNAH8
NM_001206927.2 missense

Scores

1
7
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 0.825

Publications

0 publications found
Variant links:
Genes affected
DNAH8 (HGNC:2952): (dynein axonemal heavy chain 8) The protein encoded by this gene is a heavy chain of an axonemal dynein involved in sperm and respiratory cilia motility. Axonemal dyneins generate force through hydrolysis of ATP and binding to microtubules. [provided by RefSeq, Jan 2012]
DNAH8 Gene-Disease associations (from GenCC):
  • spermatogenic failure 46
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • spermatogenic failure 5
    Inheritance: AR Classification: MODERATE Submitted by: Franklin by Genoox
  • primary ciliary dyskinesia
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.035380036).
BP6
Variant 6-38842858-A-T is Benign according to our data. Variant chr6-38842858-A-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 579789.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000545 (83/152276) while in subpopulation AFR AF = 0.00176 (73/41558). AF 95% confidence interval is 0.00143. There are 0 homozygotes in GnomAd4. There are 45 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH8NM_001206927.2 linkc.4800A>T p.Arg1600Ser missense_variant Exon 35 of 93 ENST00000327475.11 NP_001193856.1 Q96JB1Q8IU65A0A075B6F3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH8ENST00000327475.11 linkc.4800A>T p.Arg1600Ser missense_variant Exon 35 of 93 5 NM_001206927.2 ENSP00000333363.7 A0A075B6F3
DNAH8ENST00000359357.7 linkc.4149A>T p.Arg1383Ser missense_variant Exon 33 of 91 2 ENSP00000352312.3 Q96JB1-1
DNAH8ENST00000449981.6 linkc.4800A>T p.Arg1600Ser missense_variant Exon 34 of 82 5 ENSP00000415331.2 H0Y7V4

Frequencies

GnomAD3 genomes
AF:
0.000552
AC:
84
AN:
152158
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00179
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000163
AC:
41
AN:
251060
AF XY:
0.0000737
show subpopulations
Gnomad AFR exome
AF:
0.00234
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000506
AC:
74
AN:
1461560
Hom.:
0
Cov.:
31
AF XY:
0.0000413
AC XY:
30
AN XY:
727100
show subpopulations
African (AFR)
AF:
0.00182
AC:
61
AN:
33464
American (AMR)
AF:
0.0000447
AC:
2
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39628
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53396
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00000360
AC:
4
AN:
1111836
Other (OTH)
AF:
0.000116
AC:
7
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000545
AC:
83
AN:
152276
Hom.:
0
Cov.:
32
AF XY:
0.000604
AC XY:
45
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.00176
AC:
73
AN:
41558
American (AMR)
AF:
0.000131
AC:
2
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68016
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000118
Hom.:
0
Bravo
AF:
0.000623
ESP6500AA
AF:
0.00295
AC:
13
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000198
AC:
24

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 20, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.4800A>T (p.R1600S) alteration is located in exon 35 (coding exon 34) of the DNAH8 gene. This alteration results from a A to T substitution at nucleotide position 4800, causing the arginine (R) at amino acid position 1600 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DNAH8: PM2:Supporting, BP4 -

Primary ciliary dyskinesia Benign:1
Nov 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.51
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Uncertain
-0.010
CADD
Benign
17
DANN
Uncertain
1.0
DEOGEN2
Benign
0.070
T;T;T
Eigen
Benign
0.14
Eigen_PC
Benign
0.11
FATHMM_MKL
Benign
0.73
D
LIST_S2
Uncertain
0.95
D;D;D
M_CAP
Benign
0.040
D
MetaRNN
Benign
0.035
T;T;T
MetaSVM
Benign
-0.85
T
MutationAssessor
Uncertain
2.3
.;.;M
PhyloP100
0.82
PrimateAI
Uncertain
0.62
T
PROVEAN
Pathogenic
-4.8
.;D;D
REVEL
Uncertain
0.38
Sift
Benign
0.078
.;T;T
Polyphen
0.93
.;.;P
Vest4
0.65
MutPred
0.51
.;.;Loss of solvent accessibility (P = 0.1362);
MVP
0.61
MPC
0.36
ClinPred
0.17
T
GERP RS
2.7
Varity_R
0.49
gMVP
0.54
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141012833; hg19: chr6-38810634; API